CytoDyn Completes Non-dilutive $28.5 Million Convertible Note Financing with Conversion Rate at $10.00 Per Share without Warrants

CytoDyn to Hold Conference Call on July 30 to Provide Updates on its Two COVID-19 Trials

Investor Community Conference Call

Jul 30, 2020 • 4:00 pm EDT

2020 Special Meeting of Stockholders

Jul 22, 2020 • 9:30 am PDT